Results 1 - 10 of 436 : 1 2 3 4 5 6 7 8 9 Next
The Fool's Guide to Buying U.K. Retail Bonds
Earn investment income from company debt.
Buffett and Woodford Agree on This One!
Top U.S. and U.K. investors share a passion for a French pharma giant.
20 Giants for a 6% Dividend Yield
These 20 mega-cap firms pay a handsome income while you wait for growth.
With gilt yields at their lowest levels since 1703, U.K. bonds are only for fools.
The power of dividend reinvestment is beating the stock market slump.
Hostile Takeover? More Like Nice Guy Showdown.
Glaxo takes off the gloves and puts on oven mitts in bid to get Human Genome Sciences.
Glaxo Goes Hostile With $2.6 Billion Bid
GlaxoSmithKline takes its $13-a-share offer directly to Human Genome Sciences' owners.
Top blue chips for buy-and-forget investors.
Dow Poised for Further Losses?
European concerns continue to dominate the news and are likely to push the Dow lower.
A wisely chosen share delivers long-term wealth -- for generations.